Novo Nordisk's CEO, Lars Sorensen, told Reuters at the Reuters Health Summit in New York that the new diabetes drug Vict…
Byetta
Byetta Safety Label Revised
Today the FDA indicated that the safety label of Byetta would be modified to include potential kidney problems including…
Takeda and Amylin to Co-develop Obesity Treatments
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceuticals Company Limited announced an agreement to co-develop and commerc…
